Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles.

ABSTRACT:

SUBMITTER: Wang J 

PROVIDER: S-EPMC12822098 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature